been described which achieves depolarisation of central nervous tissue in the brain by pulsed electromagnetic stimulation.6 This form of stimulation is not attenuated by passage through body tissues or clothing and is virtually painfree. Repeated stimuli, which may be required to study small abnormal responses, are thus well tolerated. We have used this new technique to evaluate the usefulness of central motor conduction measurements in patients with clinically definite multiple sclerosis in remission. The electrophysiological findings have been compared with signs of weakness and upper motor neuron involvement and with clinical assessments of functional motor disability.
Patients
Twenty patients, aged between 24 and 56 (mean 38) years with clinically definite multiple sclerosis7 were studied. All had clinical evidence of relapsing and remitting disease but had been in stable clinical remission for at least one month prior to the study.8
The Kurtzke Disability Status Scale9 and the Ambulatory Index10 were used as measures of disability.
The clinical details are summarised in table 1. All patients were ambulant (Kurtzke Scale < 6). In seven N  N  3  3  3  3  3  3   1  T   2  2  7  N  N  N  N  N  N  N  N 3  3  N  N  I   1   2  1  8  N  N  N  N  N  N  N  N  3  3  3  3   t  t   2  1  19  N  N  N  N  N  N  N  N 3  3  N  N  4  4  2 Central motor conduction in multiple sclerosis: magnetic stimulation generation of descending volleys whose discharge patterns are more effective in raising the excitability of alpha motor neurons to firing threshold, thus eliciting a response in target muscles. In contrast to electrical stimulation techniques,3'5 descending motor pathways within the spinal cord, however, cannot be directly stimulated and this precludes separate evaluation of cord function.
In our patients with multiple sclerosis an increase in CMCT for leg muscles correlated with the clinical features of upper motor neuron lesions and with the degree of functional motor disability. All the patients were ambulant and abnormalities of motor conduction were revealed even in patients with mild functional disability (Kurtzke Scale 1-3) and normal strength. Although CMCTs were almost invariably increased for weak muscles, markedly increased CMCTs were found in some patients in whom strength was normal. In this latter group clinical features of upper motor neuron involvement were usually present. The magnitude of slowing of central motor conduction varied with disability, and reached a threefold change at its most severe. Similar degrees of slowing of central conduction have been recorded in experimental demyelination in the cat spinal cord"5 16 and it would be reasonable to conclude that most of the impairment we have observed in our patients with multiple sclerosis is related to demyelination. No slowing of conduction was found in the lower motor neuron segment of the motor pathway in the upper limbs. In the lower limbs there was a slight but significant increase in peripheral conduction times which suggests that a minor disturbance of peripheral motor conduction occurs in some patients.
Abnormal muscle responses following stimulation of motor pathways in the brain usually showed increased dispersion but this could not be reliably quantified because of the inherent variability in morphology of these responses to successive stimuli. This variability is a characteristic finding of motor responses elicited by cortical stimulation even in normal subjects.2 5 Increased dispersion might be related to several factors including changes in the arrival times of nerve volleys at the anterior horn cell pool of a muscle and changes in the excitability of anterior horn cells when their central connections are abnormal. Both slowing of central motor conduction and dispersion of the muscle responses may be important in understanding fatiguability in patients with multiple sclerosis. Slowing of central motor conduction is not, however, specific for multiple sclerosis; it has also been described in radiation myelitis3 and motor neuron disease5 and in association with vascular and compressive lesions. 7 CMCT measurements are thought to mainly reflect conduction in the fast-conducting corticospinal tracts.25
However, in advanced disease of the pyramidal tracts, other descending pathways such as the cortico-rubrospinal tracts" may contribute the fastest conducting fibres.
We have not attempted to compare these abnormal motor responses with the results of sensory evoked potential studies. The latter are concerned exclusively with conduction in sensory pathways which are anatomically separated from central motor tracts and would therefore not be expected to correlate with CMCTs. However there are important advantages associated with CMCT measurements. In particular, they specifically sample motor pathways and generally involve large, easily recordable muscle responses to single stimuli, even in the presence of disease. The latter characteristic avoids the need for averaging multiple responses which is required for sensory evoked potential studies. CMCT measurements are thus less time consuming and technically less demanding. They directly assess central motor pathways and provide data which can be correlated both with functional disability and with clinical signs of central motor disorders. Subclinical abnormalities ofcentral motor conduction can also be easily demonstrated. Central motor conduction time measurements using magnetic stimulation of the CNS should therefore prove valuable in the diagnosis and management of patients with multiple sclerosis and other disorders affecting central motor pathways. 
